Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Coronary Syndrome | 56 | 2021 | 2193 | 4.990 |
Why?
|
Adamantane | 23 | 2021 | 148 | 4.710 |
Why?
|
Dipeptides | 22 | 2021 | 386 | 4.270 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 20 | 2022 | 317 | 3.340 |
Why?
|
Myocardial Infarction | 86 | 2024 | 11514 | 3.190 |
Why?
|
Acetanilides | 20 | 2014 | 168 | 2.710 |
Why?
|
Diabetes Mellitus, Type 2 | 50 | 2024 | 12246 | 2.680 |
Why?
|
Platelet Aggregation Inhibitors | 36 | 2021 | 2763 | 2.640 |
Why?
|
Lactones | 21 | 2021 | 316 | 2.320 |
Why?
|
Heart Arrest | 14 | 2022 | 1516 | 1.920 |
Why?
|
Ticlopidine | 16 | 2016 | 729 | 1.880 |
Why?
|
Heart Failure | 44 | 2024 | 11879 | 1.870 |
Why?
|
Hypothermia, Induced | 9 | 2020 | 754 | 1.710 |
Why?
|
Angina, Unstable | 15 | 2016 | 893 | 1.640 |
Why?
|
Natriuretic Peptide, Brain | 19 | 2024 | 1750 | 1.610 |
Why?
|
Electrocardiography | 38 | 2021 | 6408 | 1.570 |
Why?
|
Piperazines | 23 | 2015 | 2547 | 1.570 |
Why?
|
Troponin | 8 | 2023 | 536 | 1.570 |
Why?
|
Hypoglycemic Agents | 21 | 2024 | 3108 | 1.540 |
Why?
|
Cardiovascular Diseases | 39 | 2024 | 15652 | 1.440 |
Why?
|
Angina Pectoris | 10 | 2015 | 956 | 1.380 |
Why?
|
Chest Pain | 6 | 2023 | 1101 | 1.260 |
Why?
|
Glucagon-Like Peptides | 3 | 2024 | 157 | 1.240 |
Why?
|
Pyridines | 22 | 2021 | 2888 | 1.210 |
Why?
|
Hypertension | 11 | 2023 | 8616 | 1.190 |
Why?
|
Double-Blind Method | 57 | 2024 | 12430 | 1.110 |
Why?
|
Benzazepines | 5 | 2019 | 307 | 1.070 |
Why?
|
Death, Sudden, Cardiac | 9 | 2021 | 1567 | 1.020 |
Why?
|
Secondary Prevention | 15 | 2024 | 1469 | 1.010 |
Why?
|
Receptor, PAR-1 | 9 | 2019 | 109 | 0.990 |
Why?
|
Adenosine | 7 | 2016 | 812 | 0.950 |
Why?
|
Risk Assessment | 40 | 2023 | 24299 | 0.940 |
Why?
|
Troponin T | 9 | 2023 | 786 | 0.880 |
Why?
|
Overweight | 9 | 2024 | 2447 | 0.870 |
Why?
|
C-Reactive Protein | 8 | 2024 | 3853 | 0.860 |
Why?
|
Receptors, Thrombin | 5 | 2017 | 130 | 0.830 |
Why?
|
Arrhythmias, Cardiac | 5 | 2018 | 2257 | 0.820 |
Why?
|
Pheochromocytoma | 2 | 2021 | 327 | 0.790 |
Why?
|
Thrombolytic Therapy | 16 | 2021 | 2053 | 0.790 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 2 | 2019 | 31 | 0.780 |
Why?
|
Aged | 150 | 2024 | 171344 | 0.770 |
Why?
|
Metanephrine | 1 | 2021 | 25 | 0.760 |
Why?
|
Appetite Depressants | 2 | 2019 | 108 | 0.760 |
Why?
|
Thrombotic Microangiopathies | 1 | 2023 | 125 | 0.750 |
Why?
|
Coronary Artery Disease | 16 | 2021 | 6575 | 0.750 |
Why?
|
Hypoxia, Brain | 2 | 2013 | 139 | 0.730 |
Why?
|
Aerospace Medicine | 1 | 2022 | 95 | 0.730 |
Why?
|
Obesity | 11 | 2024 | 13090 | 0.720 |
Why?
|
Tachycardia, Ventricular | 4 | 2016 | 1313 | 0.720 |
Why?
|
Humans | 254 | 2024 | 766812 | 0.720 |
Why?
|
Renal Insufficiency, Chronic | 7 | 2024 | 2306 | 0.720 |
Why?
|
Middle Aged | 148 | 2024 | 223267 | 0.700 |
Why?
|
Male | 177 | 2024 | 364154 | 0.700 |
Why?
|
Glomerular Filtration Rate | 9 | 2023 | 2232 | 0.700 |
Why?
|
Diabetic Cardiomyopathies | 2 | 2019 | 91 | 0.690 |
Why?
|
Diabetes Mellitus | 10 | 2024 | 5888 | 0.680 |
Why?
|
Potassium | 2 | 2016 | 1314 | 0.680 |
Why?
|
Glucosides | 7 | 2024 | 533 | 0.680 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2022 | 341 | 0.670 |
Why?
|
Hypercholesterolemia | 2 | 2023 | 1145 | 0.660 |
Why?
|
Disease Management | 3 | 2024 | 2533 | 0.660 |
Why?
|
Peptide Fragments | 13 | 2024 | 5143 | 0.650 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2021 | 125 | 0.650 |
Why?
|
Hospitalization | 27 | 2023 | 10816 | 0.640 |
Why?
|
Female | 177 | 2024 | 396532 | 0.640 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2021 | 732 | 0.630 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2023 | 361 | 0.620 |
Why?
|
Appetite Regulation | 1 | 2019 | 84 | 0.610 |
Why?
|
Risk Factors | 74 | 2024 | 74889 | 0.610 |
Why?
|
Myocardial Ischemia | 11 | 2016 | 2131 | 0.600 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2023 | 253 | 0.600 |
Why?
|
Sodium Channel Blockers | 3 | 2015 | 171 | 0.590 |
Why?
|
Atherosclerosis | 15 | 2024 | 3421 | 0.590 |
Why?
|
Albuminuria | 3 | 2022 | 659 | 0.590 |
Why?
|
Renal Insufficiency | 4 | 2020 | 811 | 0.580 |
Why?
|
Thrombosis | 9 | 2021 | 2953 | 0.580 |
Why?
|
Registries | 19 | 2017 | 8352 | 0.560 |
Why?
|
Kidney | 6 | 2024 | 7073 | 0.550 |
Why?
|
Enzyme Inhibitors | 14 | 2014 | 3723 | 0.550 |
Why?
|
Hypoglycemia | 5 | 2018 | 896 | 0.540 |
Why?
|
Critical Pathways | 3 | 2019 | 475 | 0.530 |
Why?
|
Peripheral Arterial Disease | 10 | 2021 | 1304 | 0.530 |
Why?
|
Benzhydryl Compounds | 8 | 2024 | 944 | 0.520 |
Why?
|
Triage | 2 | 2020 | 995 | 0.510 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2021 | 3250 | 0.500 |
Why?
|
Treatment Outcome | 66 | 2024 | 65286 | 0.490 |
Why?
|
Fibrinolytic Agents | 8 | 2020 | 2078 | 0.490 |
Why?
|
Metformin | 2 | 2020 | 907 | 0.490 |
Why?
|
Glycopeptides | 2 | 2015 | 225 | 0.480 |
Why?
|
Outpatients | 2 | 2020 | 1596 | 0.470 |
Why?
|
Coronary Disease | 6 | 2018 | 5915 | 0.460 |
Why?
|
Cardiovascular Agents | 8 | 2021 | 849 | 0.460 |
Why?
|
Medical Informatics | 1 | 2021 | 744 | 0.460 |
Why?
|
Troponin I | 5 | 2021 | 659 | 0.460 |
Why?
|
Atrial Fibrillation | 6 | 2023 | 5182 | 0.460 |
Why?
|
Diabetes Complications | 2 | 2020 | 1319 | 0.450 |
Why?
|
Body Temperature Regulation | 1 | 2015 | 292 | 0.440 |
Why?
|
Kidney Diseases | 3 | 2019 | 2101 | 0.440 |
Why?
|
Enoxaparin | 3 | 2007 | 391 | 0.430 |
Why?
|
Fumarates | 2 | 2013 | 132 | 0.430 |
Why?
|
Hypoxia-Ischemia, Brain | 4 | 2022 | 359 | 0.430 |
Why?
|
Myocardial Revascularization | 7 | 2016 | 795 | 0.430 |
Why?
|
Blood Pressure | 6 | 2023 | 8533 | 0.430 |
Why?
|
Emergency Service, Hospital | 8 | 2023 | 7870 | 0.430 |
Why?
|
Critical Care | 4 | 2015 | 2714 | 0.420 |
Why?
|
Anti-Obesity Agents | 3 | 2024 | 241 | 0.420 |
Why?
|
Cause of Death | 9 | 2024 | 3717 | 0.410 |
Why?
|
Tropanes | 3 | 2021 | 47 | 0.410 |
Why?
|
Myocardial Reperfusion | 1 | 2014 | 338 | 0.410 |
Why?
|
Clinical Protocols | 3 | 2015 | 1438 | 0.410 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.400 |
Why?
|
Stroke | 24 | 2021 | 9744 | 0.400 |
Why?
|
Valine | 2 | 2013 | 410 | 0.400 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1895 | 0.390 |
Why?
|
Coronary Circulation | 5 | 2014 | 1602 | 0.390 |
Why?
|
Telemedicine | 5 | 2024 | 3111 | 0.380 |
Why?
|
Muscarinic Antagonists | 3 | 2021 | 135 | 0.380 |
Why?
|
Amides | 2 | 2013 | 451 | 0.370 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2023 | 2143 | 0.370 |
Why?
|
Angioplasty, Balloon, Coronary | 11 | 2012 | 1721 | 0.370 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2021 | 1389 | 0.370 |
Why?
|
Shock, Cardiogenic | 6 | 2021 | 709 | 0.370 |
Why?
|
Life Support Systems | 1 | 2010 | 11 | 0.370 |
Why?
|
Time Factors | 34 | 2021 | 40149 | 0.370 |
Why?
|
Renin-Angiotensin System | 2 | 2013 | 736 | 0.360 |
Why?
|
Resuscitation | 1 | 2015 | 681 | 0.360 |
Why?
|
Kaplan-Meier Estimate | 22 | 2019 | 6514 | 0.360 |
Why?
|
Stroke Volume | 12 | 2024 | 5618 | 0.350 |
Why?
|
Spironolactone | 1 | 2014 | 415 | 0.350 |
Why?
|
Protein Precursors | 3 | 2014 | 1134 | 0.350 |
Why?
|
Prognosis | 33 | 2024 | 29959 | 0.350 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2022 | 1514 | 0.340 |
Why?
|
Electroencephalography | 7 | 2022 | 6282 | 0.330 |
Why?
|
Bradycardia | 1 | 2011 | 304 | 0.320 |
Why?
|
Electrocardiography, Ambulatory | 5 | 2013 | 582 | 0.310 |
Why?
|
Tetrazoles | 2 | 2013 | 923 | 0.300 |
Why?
|
Pyrrolidines | 2 | 2007 | 339 | 0.300 |
Why?
|
Aldosterone | 1 | 2013 | 881 | 0.300 |
Why?
|
Hospital Mortality | 9 | 2016 | 5344 | 0.290 |
Why?
|
Proportional Hazards Models | 19 | 2021 | 12536 | 0.290 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2010 | 428 | 0.280 |
Why?
|
Hyperglycemia | 3 | 2015 | 1389 | 0.280 |
Why?
|
Diabetic Nephropathies | 5 | 2018 | 975 | 0.280 |
Why?
|
Hemorrhage | 15 | 2020 | 3464 | 0.280 |
Why?
|
Placebos | 5 | 2019 | 1659 | 0.270 |
Why?
|
Death | 5 | 2020 | 685 | 0.270 |
Why?
|
Acute Disease | 10 | 2019 | 7240 | 0.260 |
Why?
|
Incidence | 22 | 2023 | 21527 | 0.260 |
Why?
|
Incretins | 2 | 2018 | 100 | 0.260 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2021 | 3246 | 0.250 |
Why?
|
Coronary Artery Bypass | 8 | 2016 | 2189 | 0.250 |
Why?
|
Ambulatory Care | 2 | 2019 | 2779 | 0.250 |
Why?
|
Creatine Kinase | 2 | 2004 | 684 | 0.250 |
Why?
|
Ventricular Function, Left | 3 | 2019 | 3934 | 0.250 |
Why?
|
Follow-Up Studies | 27 | 2019 | 39312 | 0.250 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 192 | 0.250 |
Why?
|
Survival Rate | 15 | 2016 | 12826 | 0.240 |
Why?
|
Fatal Outcome | 3 | 2021 | 1838 | 0.240 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5367 | 0.240 |
Why?
|
Coronary Angiography | 11 | 2016 | 4525 | 0.240 |
Why?
|
Creatine Kinase, MB Form | 4 | 2014 | 203 | 0.240 |
Why?
|
Cholesterol, LDL | 3 | 2023 | 2392 | 0.230 |
Why?
|
Recurrence | 13 | 2016 | 8507 | 0.230 |
Why?
|
Antithrombins | 1 | 2007 | 294 | 0.230 |
Why?
|
Heterocyclic Compounds, 2-Ring | 1 | 2024 | 38 | 0.230 |
Why?
|
Glucose | 1 | 2016 | 4340 | 0.220 |
Why?
|
Growth Differentiation Factor 15 | 2 | 2019 | 198 | 0.220 |
Why?
|
Tachycardia | 2 | 2021 | 598 | 0.220 |
Why?
|
Recovery of Function | 6 | 2021 | 2978 | 0.210 |
Why?
|
Survival Analysis | 9 | 2019 | 10101 | 0.210 |
Why?
|
Uracil | 1 | 2024 | 210 | 0.210 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1794 | 0.210 |
Why?
|
Isoenzymes | 2 | 2004 | 1688 | 0.210 |
Why?
|
Purinergic P2Y Receptor Antagonists | 3 | 2016 | 285 | 0.200 |
Why?
|
Predictive Value of Tests | 14 | 2019 | 15425 | 0.200 |
Why?
|
Thiophenes | 3 | 2015 | 570 | 0.200 |
Why?
|
Ketosis | 1 | 2022 | 46 | 0.200 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2022 | 93 | 0.200 |
Why?
|
Electronic Health Records | 4 | 2024 | 4880 | 0.200 |
Why?
|
Thrombocytopenia | 2 | 2007 | 1172 | 0.200 |
Why?
|
Quality Improvement | 2 | 2016 | 3850 | 0.200 |
Why?
|
Anticoagulants | 6 | 2023 | 4854 | 0.190 |
Why?
|
Practice Guidelines as Topic | 8 | 2024 | 7430 | 0.190 |
Why?
|
Pharmacists | 1 | 2024 | 261 | 0.190 |
Why?
|
Coronary Thrombosis | 2 | 2014 | 440 | 0.190 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2006 | 519 | 0.190 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1936 | 0.180 |
Why?
|
Early Termination of Clinical Trials | 1 | 2021 | 70 | 0.180 |
Why?
|
Inpatients | 1 | 2012 | 2566 | 0.180 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2021 | 109 | 0.180 |
Why?
|
Body Mass Index | 8 | 2024 | 13050 | 0.180 |
Why?
|
Prospective Studies | 20 | 2022 | 54872 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 13 | 2024 | 10384 | 0.180 |
Why?
|
Thrombin | 3 | 2021 | 600 | 0.180 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2021 | 1241 | 0.170 |
Why?
|
Glycosides | 1 | 2020 | 99 | 0.170 |
Why?
|
Aged, 80 and over | 20 | 2020 | 59548 | 0.170 |
Why?
|
Weight Loss | 4 | 2019 | 2712 | 0.170 |
Why?
|
Myoclonus | 1 | 2020 | 107 | 0.170 |
Why?
|
Inflammation | 2 | 2019 | 10863 | 0.170 |
Why?
|
Algorithms | 9 | 2022 | 14073 | 0.170 |
Why?
|
Multivariate Analysis | 10 | 2017 | 12064 | 0.160 |
Why?
|
Coma | 2 | 2015 | 485 | 0.160 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 489 | 0.160 |
Why?
|
Cohort Studies | 12 | 2024 | 41706 | 0.160 |
Why?
|
Automation | 1 | 2021 | 586 | 0.160 |
Why?
|
Blood Glucose | 6 | 2021 | 6422 | 0.160 |
Why?
|
Echocardiography | 3 | 2021 | 5038 | 0.150 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2022 | 1065 | 0.150 |
Why?
|
Patient Discharge | 6 | 2019 | 3466 | 0.150 |
Why?
|
Purinergic P2 Receptor Antagonists | 2 | 2009 | 67 | 0.150 |
Why?
|
Ischemia | 3 | 2021 | 1905 | 0.150 |
Why?
|
Pulmonary Edema | 1 | 2021 | 409 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13489 | 0.150 |
Why?
|
Disease Progression | 9 | 2023 | 13642 | 0.150 |
Why?
|
Heart Valve Diseases | 1 | 2006 | 1029 | 0.150 |
Why?
|
Sex Factors | 8 | 2021 | 10619 | 0.150 |
Why?
|
Guideline Adherence | 3 | 2024 | 2233 | 0.150 |
Why?
|
Neurologic Examination | 2 | 2018 | 913 | 0.150 |
Why?
|
United States Food and Drug Administration | 4 | 2020 | 1673 | 0.150 |
Why?
|
Anticholesteremic Agents | 1 | 2005 | 970 | 0.150 |
Why?
|
Radiography, Thoracic | 2 | 2021 | 1320 | 0.150 |
Why?
|
Drug Therapy | 1 | 2021 | 504 | 0.150 |
Why?
|
Decision Support Techniques | 3 | 2019 | 2007 | 0.140 |
Why?
|
Syndrome | 5 | 2007 | 3271 | 0.140 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2016 | 1457 | 0.140 |
Why?
|
Dyspnea | 3 | 2023 | 1352 | 0.140 |
Why?
|
Aspirin | 5 | 2014 | 3134 | 0.140 |
Why?
|
United States | 23 | 2023 | 72945 | 0.140 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 832 | 0.140 |
Why?
|
Pancreatitis | 2 | 2014 | 1087 | 0.140 |
Why?
|
Myocardium | 3 | 2021 | 4765 | 0.140 |
Why?
|
Workflow | 1 | 2021 | 859 | 0.130 |
Why?
|
Neopterin | 2 | 2011 | 57 | 0.130 |
Why?
|
Electric Countershock | 1 | 2019 | 534 | 0.130 |
Why?
|
Drug Labeling | 1 | 2018 | 251 | 0.130 |
Why?
|
Quality of Life | 7 | 2023 | 13476 | 0.130 |
Why?
|
Drug Administration Schedule | 3 | 2015 | 4853 | 0.130 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2010 | 577 | 0.130 |
Why?
|
Risk | 7 | 2019 | 9602 | 0.130 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2015 | 996 | 0.130 |
Why?
|
Collagen Type I | 1 | 2019 | 616 | 0.130 |
Why?
|
Peripheral Vascular Diseases | 1 | 2018 | 488 | 0.130 |
Why?
|
Infarction | 1 | 2017 | 247 | 0.130 |
Why?
|
Diet, Reducing | 1 | 2019 | 487 | 0.120 |
Why?
|
Retrospective Studies | 17 | 2023 | 81657 | 0.120 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 772 | 0.120 |
Why?
|
Calibration | 1 | 2017 | 814 | 0.120 |
Why?
|
Physical Stimulation | 1 | 2016 | 514 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2017 | 592 | 0.120 |
Why?
|
Drug Therapy, Combination | 7 | 2021 | 6306 | 0.120 |
Why?
|
Electrodiagnosis | 1 | 2015 | 149 | 0.120 |
Why?
|
Lung | 3 | 2021 | 10068 | 0.110 |
Why?
|
Alanine | 2 | 2007 | 613 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2021 | 10745 | 0.110 |
Why?
|
Prevalence | 7 | 2024 | 15835 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2334 | 0.110 |
Why?
|
Galvanic Skin Response | 1 | 2015 | 359 | 0.110 |
Why?
|
Coronary Occlusion | 1 | 2016 | 284 | 0.110 |
Why?
|
Exercise Test | 3 | 2016 | 2188 | 0.110 |
Why?
|
Pravastatin | 3 | 2016 | 391 | 0.100 |
Why?
|
Ischemic Attack, Transient | 2 | 2015 | 874 | 0.100 |
Why?
|
Brain Waves | 1 | 2017 | 416 | 0.100 |
Why?
|
Military Personnel | 1 | 2022 | 1260 | 0.100 |
Why?
|
Confidence Intervals | 4 | 2014 | 2921 | 0.100 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 2030 | 0.100 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2015 | 270 | 0.100 |
Why?
|
Patient Admission | 2 | 2019 | 1364 | 0.100 |
Why?
|
Thiazolidinediones | 1 | 2015 | 460 | 0.100 |
Why?
|
Cholesterol | 1 | 2021 | 2904 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1120 | 0.100 |
Why?
|
Prescriptions | 1 | 2015 | 388 | 0.100 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2012 | 59 | 0.100 |
Why?
|
Pyrimidines | 1 | 2024 | 3043 | 0.100 |
Why?
|
Forced Expiratory Volume | 3 | 2021 | 1828 | 0.100 |
Why?
|
Mortality | 2 | 2021 | 2908 | 0.100 |
Why?
|
Logistic Models | 7 | 2017 | 13276 | 0.100 |
Why?
|
Coronary Care Units | 1 | 2013 | 235 | 0.100 |
Why?
|
Acoustic Stimulation | 1 | 2016 | 1253 | 0.100 |
Why?
|
Vascular Surgical Procedures | 2 | 2020 | 1506 | 0.100 |
Why?
|
Odds Ratio | 6 | 2016 | 9661 | 0.090 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1478 | 0.090 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 1399 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2023 | 0.090 |
Why?
|
Vascular Patency | 2 | 2016 | 915 | 0.090 |
Why?
|
Osteoprotegerin | 1 | 2012 | 179 | 0.090 |
Why?
|
Thoracic Surgical Procedures | 1 | 2015 | 348 | 0.090 |
Why?
|
Platelet Activation | 2 | 2011 | 643 | 0.090 |
Why?
|
Diabetic Angiopathies | 3 | 2015 | 806 | 0.090 |
Why?
|
Advisory Committees | 1 | 2015 | 797 | 0.090 |
Why?
|
Sodium-Glucose Transporter 2 | 2 | 2023 | 89 | 0.090 |
Why?
|
Osteoporotic Fractures | 1 | 2015 | 415 | 0.090 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 246 | 0.090 |
Why?
|
Placebo Effect | 1 | 2014 | 515 | 0.090 |
Why?
|
France | 1 | 2011 | 496 | 0.090 |
Why?
|
Intracranial Hemorrhages | 2 | 2013 | 810 | 0.090 |
Why?
|
Thromboembolism | 1 | 2017 | 1003 | 0.090 |
Why?
|
Omeprazole | 1 | 2010 | 106 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2053 | 0.080 |
Why?
|
Comorbidity | 6 | 2015 | 10580 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2022 | 2058 | 0.080 |
Why?
|
Temperature | 1 | 2016 | 2231 | 0.080 |
Why?
|
Brain Diseases | 1 | 2018 | 1552 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20146 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1663 | 0.080 |
Why?
|
Patient Selection | 3 | 2024 | 4252 | 0.080 |
Why?
|
Ventricular Premature Complexes | 1 | 2010 | 112 | 0.080 |
Why?
|
Israel | 1 | 2011 | 726 | 0.080 |
Why?
|
Age Factors | 6 | 2019 | 18397 | 0.080 |
Why?
|
Conscious Sedation | 1 | 2013 | 534 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2021 | 15912 | 0.080 |
Why?
|
Analgesia | 1 | 2013 | 461 | 0.080 |
Why?
|
Defibrillators, Implantable | 2 | 2016 | 1499 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2869 | 0.080 |
Why?
|
Heart Conduction System | 1 | 2014 | 1008 | 0.080 |
Why?
|
Drug-Eluting Stents | 1 | 2014 | 681 | 0.080 |
Why?
|
Heptanoic Acids | 2 | 2011 | 344 | 0.080 |
Why?
|
Fibrinolysis | 1 | 2010 | 331 | 0.080 |
Why?
|
Adult | 20 | 2024 | 223305 | 0.080 |
Why?
|
Obesity, Abdominal | 1 | 2011 | 372 | 0.070 |
Why?
|
Patient Care Team | 1 | 2019 | 2519 | 0.070 |
Why?
|
Independent Living | 1 | 2012 | 584 | 0.070 |
Why?
|
Cardiology | 2 | 2019 | 1701 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2020 | 1880 | 0.070 |
Why?
|
Renin | 1 | 2010 | 647 | 0.070 |
Why?
|
Pilot Projects | 2 | 2019 | 8728 | 0.070 |
Why?
|
Drug Approval | 1 | 2015 | 820 | 0.070 |
Why?
|
Length of Stay | 2 | 2019 | 6491 | 0.070 |
Why?
|
Insulin-Secreting Cells | 1 | 2015 | 899 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1883 | 0.070 |
Why?
|
Bronchodilator Agents | 2 | 2021 | 513 | 0.070 |
Why?
|
Peroxidase | 1 | 2010 | 610 | 0.070 |
Why?
|
Administration, Inhalation | 2 | 2021 | 1154 | 0.070 |
Why?
|
Warfarin | 3 | 2023 | 1493 | 0.070 |
Why?
|
Family Characteristics | 1 | 2012 | 1002 | 0.070 |
Why?
|
Chi-Square Distribution | 4 | 2016 | 3431 | 0.070 |
Why?
|
Peptides | 1 | 2019 | 4347 | 0.070 |
Why?
|
Data Mining | 1 | 2012 | 560 | 0.070 |
Why?
|
Postoperative Hemorrhage | 1 | 2010 | 418 | 0.070 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14762 | 0.070 |
Why?
|
Endovascular Procedures | 2 | 2020 | 2215 | 0.070 |
Why?
|
Insulin | 3 | 2016 | 6608 | 0.070 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 499 | 0.070 |
Why?
|
Evidence-Based Medicine | 4 | 2014 | 3692 | 0.060 |
Why?
|
Research Design | 4 | 2019 | 6206 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3926 | 0.060 |
Why?
|
Down-Regulation | 1 | 2013 | 2931 | 0.060 |
Why?
|
Calcium Channel Blockers | 2 | 2022 | 687 | 0.060 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2006 | 153 | 0.060 |
Why?
|
Proton Pump Inhibitors | 1 | 2010 | 550 | 0.060 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 932 | 0.060 |
Why?
|
Ventricular Function | 1 | 2006 | 403 | 0.060 |
Why?
|
Electrophysiology | 1 | 2007 | 1263 | 0.060 |
Why?
|
Probability | 1 | 2010 | 2476 | 0.060 |
Why?
|
Heart-Assist Devices | 1 | 2015 | 1287 | 0.060 |
Why?
|
Iron | 1 | 2013 | 1812 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12985 | 0.060 |
Why?
|
Pyrroles | 2 | 2011 | 1121 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4591 | 0.060 |
Why?
|
Brain Ischemia | 2 | 2014 | 3001 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2009 | 698 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 36570 | 0.060 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2015 | 1481 | 0.050 |
Why?
|
Heart Diseases | 1 | 2016 | 2817 | 0.050 |
Why?
|
Chronic Disease | 4 | 2016 | 9358 | 0.050 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2010 | 1126 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6329 | 0.050 |
Why?
|
Medication Adherence | 1 | 2015 | 2190 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2016 | 3618 | 0.050 |
Why?
|
Injections, Subcutaneous | 1 | 2024 | 684 | 0.050 |
Why?
|
Electronic Mail | 1 | 2024 | 215 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3951 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14653 | 0.050 |
Why?
|
Retreatment | 2 | 2015 | 598 | 0.050 |
Why?
|
Informatics | 1 | 2022 | 72 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2815 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2005 | 642 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2013 | 2727 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3283 | 0.050 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2022 | 69 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6214 | 0.050 |
Why?
|
Massachusetts | 1 | 2014 | 8890 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12808 | 0.050 |
Why?
|
Ketones | 1 | 2022 | 183 | 0.050 |
Why?
|
Receptors, Angiotensin | 1 | 2021 | 141 | 0.050 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2020 | 108 | 0.040 |
Why?
|
Biology | 1 | 2022 | 292 | 0.040 |
Why?
|
Bilirubin | 1 | 2022 | 440 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2006 | 1459 | 0.040 |
Why?
|
Choline | 1 | 2022 | 511 | 0.040 |
Why?
|
Creatine | 1 | 2022 | 424 | 0.040 |
Why?
|
Models, Animal | 1 | 2006 | 2121 | 0.040 |
Why?
|
Diet | 1 | 2017 | 8088 | 0.040 |
Why?
|
Creatinine | 2 | 2016 | 1917 | 0.040 |
Why?
|
Hirudins | 2 | 2010 | 179 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2022 | 575 | 0.040 |
Why?
|
Computational Biology | 1 | 2011 | 3564 | 0.040 |
Why?
|
Product Labeling | 1 | 2020 | 75 | 0.040 |
Why?
|
Drug Utilization | 2 | 2019 | 1188 | 0.040 |
Why?
|
Models, Cardiovascular | 2 | 2017 | 978 | 0.040 |
Why?
|
Extremities | 2 | 2016 | 869 | 0.040 |
Why?
|
Stents | 2 | 2008 | 3193 | 0.040 |
Why?
|
Vital Capacity | 1 | 2021 | 995 | 0.040 |
Why?
|
Internationality | 2 | 2015 | 1006 | 0.040 |
Why?
|
Medical History Taking | 1 | 2022 | 779 | 0.040 |
Why?
|
Neprilysin | 1 | 2021 | 487 | 0.040 |
Why?
|
Boston | 2 | 2024 | 9346 | 0.040 |
Why?
|
Heparin | 3 | 2010 | 1636 | 0.040 |
Why?
|
Medicare | 1 | 2016 | 6813 | 0.040 |
Why?
|
Models, Statistical | 1 | 2012 | 5092 | 0.040 |
Why?
|
Diabetic Ketoacidosis | 1 | 2020 | 252 | 0.040 |
Why?
|
Mycoses | 1 | 2020 | 389 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1622 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2006 | 1790 | 0.030 |
Why?
|
Databases, Factual | 2 | 2022 | 8065 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2014 | 5444 | 0.030 |
Why?
|
Consciousness | 1 | 2022 | 602 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2126 | 0.030 |
Why?
|
Systole | 1 | 2018 | 935 | 0.030 |
Why?
|
Diastole | 1 | 2018 | 784 | 0.030 |
Why?
|
Glyburide | 1 | 2016 | 117 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2721 | 0.030 |
Why?
|
Sulfonylurea Compounds | 1 | 2016 | 220 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1806 | 0.030 |
Why?
|
Insulin Resistance | 2 | 2021 | 3989 | 0.030 |
Why?
|
Aortic Valve Insufficiency | 1 | 2018 | 575 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2006 | 2505 | 0.030 |
Why?
|
Diarrhea | 1 | 2020 | 1317 | 0.030 |
Why?
|
International Agencies | 1 | 2014 | 244 | 0.030 |
Why?
|
Limb Salvage | 1 | 2016 | 488 | 0.030 |
Why?
|
Recombinant Proteins | 3 | 2010 | 6507 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2023 | 1445 | 0.030 |
Why?
|
Serum Albumin | 1 | 2016 | 676 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2006 | 3582 | 0.030 |
Why?
|
Hemodynamics | 2 | 2015 | 4188 | 0.030 |
Why?
|
Brugada Syndrome | 1 | 2014 | 98 | 0.030 |
Why?
|
Atrial Natriuretic Factor | 1 | 2014 | 350 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2018 | 904 | 0.030 |
Why?
|
Prediabetic State | 1 | 2018 | 547 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2413 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2013 | 163 | 0.020 |
Why?
|
Sodium | 1 | 2017 | 1594 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2012 | 222 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3681 | 0.020 |
Why?
|
Heart Rate | 2 | 2014 | 4207 | 0.020 |
Why?
|
Catalysis | 1 | 2013 | 767 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22248 | 0.020 |
Why?
|
Norway | 1 | 2012 | 500 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20710 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2019 | 1220 | 0.020 |
Why?
|
Heart | 1 | 2023 | 4425 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2011 | 8045 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2022 | 2809 | 0.020 |
Why?
|
Loneliness | 1 | 2012 | 211 | 0.020 |
Why?
|
Platelet Function Tests | 1 | 2011 | 275 | 0.020 |
Why?
|
Administration, Oral | 2 | 2008 | 4019 | 0.020 |
Why?
|
Thiazoles | 1 | 2017 | 1529 | 0.020 |
Why?
|
Pregnancy | 2 | 2012 | 30236 | 0.020 |
Why?
|
Fasting | 1 | 2015 | 1609 | 0.020 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2010 | 344 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2015 | 872 | 0.020 |
Why?
|
Body Weight | 1 | 2018 | 4626 | 0.020 |
Why?
|
Waist Circumference | 1 | 2011 | 934 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2011 | 682 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1604 | 0.020 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2007 | 117 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 2 | 2014 | 3683 | 0.020 |
Why?
|
Homozygote | 1 | 2011 | 1775 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2221 | 0.020 |
Why?
|
Anthropometry | 1 | 2011 | 1336 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22350 | 0.020 |
Why?
|
Immunoassay | 1 | 2010 | 744 | 0.020 |
Why?
|
International Cooperation | 1 | 2013 | 1434 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4087 | 0.020 |
Why?
|
India | 1 | 2013 | 2335 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2019 | 3799 | 0.020 |
Why?
|
Drug Interactions | 1 | 2010 | 1419 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2009 | 1180 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3430 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2783 | 0.020 |
Why?
|
Truth Disclosure | 1 | 2009 | 433 | 0.020 |
Why?
|
Sex Distribution | 1 | 2010 | 2274 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2144 | 0.010 |
Why?
|
Brain | 2 | 2022 | 27158 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2021 | 15831 | 0.010 |
Why?
|
Heterozygote | 1 | 2011 | 2795 | 0.010 |
Why?
|
Goals | 1 | 2010 | 717 | 0.010 |
Why?
|
Drug Resistance | 1 | 2010 | 1592 | 0.010 |
Why?
|
Young Adult | 2 | 2023 | 59939 | 0.010 |
Why?
|
Exercise Tolerance | 1 | 2009 | 845 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3803 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26309 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8734 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5873 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1540 | 0.010 |
Why?
|
Societies, Medical | 1 | 2015 | 3957 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2418 | 0.010 |
Why?
|
Long-Term Care | 1 | 2006 | 630 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 18076 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1804 | 0.010 |
Why?
|
Microcirculation | 1 | 2006 | 1282 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1733 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2012 | 1931 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2010 | 2645 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42577 | 0.010 |
Why?
|
Clinical Competence | 1 | 2015 | 4858 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9077 | 0.010 |
Why?
|
Streptokinase | 1 | 1998 | 186 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 5990 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2006 | 1161 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2012 | 2662 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8540 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 13036 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 88902 | 0.010 |
Why?
|
Child | 1 | 2022 | 80670 | 0.010 |
Why?
|
Animals | 1 | 2006 | 168939 | 0.010 |
Why?
|
Tissue Plasminogen Activator | 1 | 1998 | 1164 | 0.010 |
Why?
|
Emergencies | 1 | 1998 | 1223 | 0.010 |
Why?
|
Hospitals | 1 | 2005 | 3885 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2005 | 3927 | 0.010 |
Why?
|